Syringaresinol: Exploring Its Natural Sources, Bioactivity, and Health Benefits
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202500352 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Ibrahim Mssillou und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Agency of Medicinal and Aromatic Plants, Taounate, Morocco. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Biological Products, Furans, Lignans. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 170 Literaturangaben. Gefördert von: The authors gratfully acknowledge the funding of the Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia, Through Project numb….
Abstract (Originalsprache)
Syringaresinol (SYR) is a dietary lignan largely known for its therapeutic effects. Thus, our present review provides an overview of the natural sources and chemistry of this molecule and discusses its biological and pharmacological properties. Indeed, SYR is widely distributed in the plant kingdom and has been reported in 87 species distributed over 40 families. Its main sources are Acanthopanax and Albizia genera. It has also been identified and purified from Cinnamomum cassia and Panax ginseng C.A. Mey. Interestingly, SYR has an important anti‐inflammatory effect and is implicated in multiple mechanistic pathways, including the inhibition of iNOS, cyclooxygenase‐2 (COX‐2), and the decrease of NF‐κB, nitric oxide (NO), PGE2, tumor necrosis factor‐α (TNF‐α), IL‐1β, and IL‐6 levels. In cancer treatment, SYR induces cell cycle arrest, increases the expression of p21 waf1/cip1 and p27 kip1 , and causes a downregulation of cyclins and cyclin‐dependent kinases (CDKs). SYR improves cardiac function via ER/SIRT1/NLRP3/GSDMD and has a protective effect against hypoxia/reoxygenation injury. Although some toxicological studies have confirmed its safety, nevertheless, further examinations are necessary to prove its pharmacological stability. Unfortunately, there is a major lack of human clinical investigations on SYR. Therefore, it is strongly advised to focus on this side to better recommend this substance as a dietary agent for various human health complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Agency of Medicinal and Aromatic Plants, Taounate, Morocco.
- The Higher Institute of Nursing Professions and Health Techniques (ISPITS), Fez, Morocco.
- Laboratory of Cell Biology and Molecular Genetics (LBCGM), Department of Biology, Faculty of Sciences, Ibn Zohr University, Agadir, Morocco.
- Health Research Center, Jazan University, Jazan, Saudi Arabia.
- Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
ORCID-Profile: Ibrahim Mssillou
Förderung
- The authors gratfully acknowledge the funding of the Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia, Through Project numb…
Zitieren
APA
Mssillou, I., Bakour, M., Amrati, F. E., Oraibi, B., Elmobark, M. E., & Khalid, A. (2025). Syringaresinol: Exploring Its Natural Sources, Bioactivity, and Health Benefits. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500352
Vancouver
Mssillou I, Bakour M, Amrati FE, Oraibi B, Elmobark ME, Khalid A. Syringaresinol: Exploring Its Natural Sources, Bioactivity, and Health Benefits. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500352
BibTeX
@article{Mssillou2025,
author = {Mssillou, Ibrahim and Bakour, Meryem and Amrati, Fatima Ez-Zahra and Oraibi, Bassem and Elmobark, Mohamed Eltaib and Khalid, Asaad},
title = {Syringaresinol: Exploring Its Natural Sources, Bioactivity, and Health Benefits},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202500352}
}
EUVIMED